Try our beta test site

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

This study has been terminated.
(Termination of the clinical development program by the Sponsor)
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche
ClinicalTrials.gov Identifier:
NCT01059682
First received: January 29, 2010
Last updated: August 8, 2016
Last verified: August 2016